Dhanvantri Jeevan Rekha Ltd (ZDHJERK) — shareholding pattern, promoter holding, financials and share price
About Dhanvantri Jeevan Rekha Ltd (ZDHJERK)
Dhanvantri Jeevan Rekha Ltd operates in the Healthcare Service Provider industry, within the Healthcare sector. It trades on the NSE as ZDHJERK and on the BSE under scrip code 531043. Its ISIN is INE239F01015.
Incorporated in 1993, Dhanvantri Jeevan Rekha Ltd provides Medical and Health-care Services. [1]
Dhanvantri Jeevan Rekha Limited operates a comprehensive multi-specialty hospital in Meerut, India. It provides diagnostic and therapeutic services across various medical fields.
The hospital offers state-of-the-art facilities including a fully operational Cath Lab and advanced diagnostic equipment like MRI.
Listed peers in Healthcare Service Provider: Family Care Hospitals Ltd, Clinitech Laboratory Ltd, Looks Health Services Ltd, Dr Lalchandani Labs Ltd, Ashram Online.com Ltd, Gian Lifecare Ltd.
Valuation & Returns
10 Jul 2026At ₹27.4 a share on 10 Jul 2026, Dhanvantri Jeevan Rekha Ltd (ZDHJERK) was valued at a price-to-earnings ratio of 28.79x against an industry P/E of 61.73x and a price-to-book of 1.11x on a book value of ₹24.72 per share as of Mar 2025. Solomo computes return on equity of 3.85% and return on capital employed of 3.85% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 28.79x
- Industry P/E
- 61.73x
- P/B
- 1.11x
- EPS (TTM)
- ₹0.95
- Book value / share
- ₹24.72
- ROE
- 3.85%
- ROCE
- 3.85%
- ROA
- 2.64%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- 4.18%
- 52-week range
- ₹19 – ₹35.86
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Dhanvantri Jeevan Rekha Ltd (ZDHJERK) reported revenue of ₹25.86 crore, net profit of ₹0.4 crore and earnings per share of ₹0.98. That compares with revenue of ₹22.65 crore and net profit of ₹0.51 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹7.24 crore and net profit ₹0.3 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 16.77 | 17.68 | 20.46 | 22.65 | 25.86 |
| Net profit (₹ cr) | 0.49 | -0.22 | 0.17 | 0.51 | 0.4 |
| EPS (₹) | 1.2 | -0.54 | 0.41 | 1.24 | 0.98 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 10.45% | 4.46% | 10.54% | 10.70% |
| Profit growth | -6.79% | - | 1.08% | 200.00% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 19.65% of Dhanvantri Jeevan Rekha Ltd (ZDHJERK) (unchanged from the previous quarter). Market capitalisation was ₹11 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: Rowena Sharma 9.43%, Investor Education and Protection Fund (IEPF) 6.74%, Deepak Kapoor 4.67%, Tulsi Prasad Sharma 2.44%, GLASTON MARIO MENEZES 1.96%, Abdulazeem I Majgaonkar 1.73%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 19.65% | - | - | - | 80.35% |
| Mar 2026 | 19.65% | - | - | - | 80.35% |
| Dec 2025 | 19.65% | - | - | - | 80.35% |
| Sep 2025 | 19.65% | - | - | - | 80.35% |
| Jun 2025 | 19.65% | - | - | - | 80.35% |
| Mar 2025 | 19.65% | - | - | - | 80.35% |
| Dec 2024 | 19.65% | - | - | - | 80.35% |
| Sep 2024 | 19.65% | - | - | - | 80.35% |